IceCure Medical (ICCM) Projected to Post Earnings on Thursday

IceCure Medical (NASDAQ:ICCM) is expected to release its earnings data before the market opens on Thursday, March 27th. Analysts expect IceCure Medical to post earnings of ($0.07) per share and revenue of $1.07 million for the quarter. Persons that are interested in participating in the company’s earnings conference call can do so using this link.

IceCure Medical Stock Performance

NASDAQ:ICCM opened at $1.29 on Tuesday. The firm’s fifty day simple moving average is $1.32 and its 200-day simple moving average is $0.98. The company has a quick ratio of 2.27, a current ratio of 2.67 and a debt-to-equity ratio of 0.02. The stock has a market cap of $71.60 million, a PE ratio of -4.45 and a beta of 0.37. IceCure Medical has a fifty-two week low of $0.48 and a fifty-two week high of $1.66.

Wall Street Analysts Forecast Growth

Separately, HC Wainwright reaffirmed a “buy” rating and issued a $2.50 target price on shares of IceCure Medical in a report on Wednesday, November 27th.

About IceCure Medical

IceCure Medical Ltd, a commercial stage medical device company, engages in the research, development, and marketing of cryoablation systems, disposables, and technologies for treating tumors. The company offers ProSense system, a single probe system for the treatment of tumors, as well as associated disposables; and IceSense3 system for ablation indications to urology, oncology, dermatology, gynecology, general surgery, thoracic surgery, and proctology.